在老年NSCLC患者的免疫性和免疫疗法
Jing Zhang1,2, Linlin Zhao1,2, Huzi Li1,2
1Department of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Journal of cancer research and therapeutics
|March 30, 2024
概括
免疫检查点抑制剂 (ICI) 为老年非小细胞肺癌 (NSCLC) 患者提供了新的希望. 本综述检查了ICI在老年NSCLC患者的疗效和免疫效应,这些人表现不佳.
科学领域:
- 在瘤学瘤学.
- 免疫疗法是一种免疫疗法.
- 老年医学 老年医学
背景情况:
- 非小细胞肺癌 (NSCLC) 不成比例地影响65岁以上的人.
- 免疫检查点抑制剂 (ICI) 已经改变了NSCLC的治疗模式.
- 关于ICI在老年NSCLC患者的疗效和安全性的数据有限,这些患者往往患有并发症.
研究的目的:
- 审查临床试验数据ICI在老年NSCLC患者的低绩效状态.
- 为了探索免疫性质在免疫治疗反应中的作用,对于这个人口群体.
- 讨论用于预测ICI在先进NSCLC中的疗效的生物标志物.
主要方法:
- 对临床试验数据的系统审查,重点关注老年NSCLC患者.
- 对免疫衰变标志物的分析及其与治疗结果的相关性.
- 对ICI治疗的预测生物标志物的评估.
主要成果:
- 关于老年NSCLC患者的ICI疗效的数据综合,其表现状况不佳.
- 洞察免疫性如何影响老年人的免疫疗法反应.
- 识别针对个性化治疗策略的潜在生物标志物.
结论:
- 了解ICI在老年NSCLC患者的疗效对于优化癌症护理至关重要.
- 免疫性和生物标志物是预测治疗成功的关键因素.
- 需要进一步的研究来完善NSCLC的老年人免疫疗法方法.
相关概念视频
Tumor Immunotherapy
523
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
523
Cancer Vaccines
363
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
363
Cytotoxic T Cells-mediated Immune Response
907
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
907
Cell-mediated Immune Responses
68.2K
Overview
68.2K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K


